1. Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention
- Author
-
Betty M Rupp, Aditya H. Gaur, Barbara Heckman, Rachel West Goolsby, Michael G. Hudgens, Melissa Polier, Ini Ubong, Keith J. Horvath, Megan Mueller Johnson, Teresa Filipowicz, K. Rivet Amico, Ronald H. Dallas, Jessica Crawford, and Jane C. Lindsey
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,Anti-HIV Agents ,Psychological intervention ,HIV Infections ,Viremia ,Medication Adherence ,Young Adult ,03 medical and health sciences ,Social support ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,medicine ,Humans ,030212 general & internal medicine ,Psychiatry ,Depression (differential diagnoses) ,030505 public health ,business.industry ,Clinical and Epidemiologic Research ,Public Health, Environmental and Occupational Health ,Viral Load ,medicine.disease ,Mental health ,United States ,Clinical trial ,Infectious Diseases ,0305 other medical science ,business ,Viral load - Abstract
A sizable portion of youth (ages 13–24) living with HIV in the United States have unsuppressed viral load. The AIDS Interventions (ATN) 152 study [evaluating the Triggered Escalating Real-Time Adherence (TERA) intervention] baseline data were examined to identify correlates of high viremia (>5000 copies/mL) and self-reported adherence, which can help in planning of differentiated services for viremic youth. Depression, HIV-stigma, and cannabis use were common in this sample of 87 youth. Almost half (48%) had high viremia, which associated with enacted stigma, moderate- to high-risk alcohol use, mental health diagnosis, and age ≥21. Self-reported adherence was related to viral load and associated with mental and physical health functioning, depression, social support, self-confident decision-making, total and internalized stigma, adherence motivation, and report of a missed a care visit in the past 6 months. Mental health emerged as a common correlate of viral load and adherence. Clinical Trial Registration number: NCT03292432.
- Published
- 2021